<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="topic" /><meta name="keywords" content="" /><title>Method: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="37413.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="37413.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=37413.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="37408.htm">Appendix 4 Intravenous additives</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="37412.htm" title="Previous: Problems">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="37414.htm" title="Next: Use of table">Next page</a> ►</div></div></div></div><div id="p1"><div id="pB"><h1 id="_37413">Method</h1><?highlighter on?><div id="pC" class="jN"><p>Ready-prepared infusions should be used whenever available. <b><span>Potassium chloride</span></b> is usually available
in concentrations of 20, 27, and 40 mmol/litre in <span>sodium
chloride</span> intravenous infusion (0.9%), <span>glucose</span> intravenous infusion (5%) or <span>sodium chloride</span> and <span>glucose</span> intravenous infusion. <b>Lidocaine hydrochloride</b> is usually available in concentrations of 0.1 or 0.2% in <span>glucose</span> intravenous infusion (5%).</p><p>When addition is required to be made extemporaneously, any product
reconstitution instructions such as those relating to concentration,
vehicle, mixing, and handling precautions should be strictly followed
using an aseptic technique throughout. Once the product has been reconstituted,
addition to the infusion fluid should be made immediately in order
to minimise microbial contamination and, with certain products, to
prevent degradation or other formulation change which may occur; e.g.
reconstituted <span>ampicillin</span> injection degrades rapidly
on standing, and also may form polymers which could cause sensitivity
reactions.</p><p>It is also important in certain instances that an infusion fluid
of specific pH be used (e.g. <b>furosemide</b> injection
requires dilution in infusions of pH greater than 5.5).</p><p>When drug additions are made it is important to mix thoroughly;
additions should not be made to an infusion container that has been
connected to a giving set, as mixing is hampered. If the solutions
are not thoroughly mixed a concentrated layer of the additive may
form owing to differences in density. <b><span>Potassium chloride</span></b> is particularly prone to this ‘layering’ effect when added
without adequate mixing to infusions packed in non-rigid infusion
containers; if such a mixture is administered it may have a serious
effect on the heart.</p><p>A time limit between addition and completion of administration
must be imposed for certain admixtures to guarantee satisfactory drug
potency and compatibility. For admixtures in which degradation occurs
without the formation of toxic substances, an acceptable limit is
the time taken for 10% decomposition of the drug. When toxic substances
are produced stricter limits may be imposed. Because of the risk of
microbial contamination a maximum time limit of 24 hours may be appropriate
for additions made elsewhere than in hospital pharmacies offering
central additive service.</p><p>Certain injections must be protected from light during continuous
infusion to minimise oxidation, e.g. <span>amphotericin</span>, <span>dacarbazine</span>, and <span>sodium nitroprusside</span>.</p><p>Dilution with a small volume of an appropriate vehicle and administration
using a motorised infusion pump is advocated for preparations such
as unfractionated <span>heparin</span> where strict control
over administration is required. In this case the appropriate dose
may be dissolved in a convenient volume (e.g. 24–48 mL) of <span>sodium chloride</span> intravenous infusion (0.9%).</p></div><?highlighter on?><?highlighter off?><div id="pE">◄ <a accesskey="[" href="37412.htm">Previous: Problems</a> | <a class="top" href="37413.htm#">Top</a> | <a accesskey="]" href="37414.htm">Next: Use of table</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>